A comparison of susceptibility to photodynamic treatment between endothelial and tumor cells in vitro and in vivo

Photodiagnosis and Photodynamic Therapy

Volumn 4, Issue 3, 2007, Pages 160-169

  Moore, Ronald B ^a   Xiao, Zhengwen ^a   Tulip, John ^a   Chapman, J D ^a  

^a CROSS CANCER INSTITUTE   (Canada)

Author keywords

Endothelial cells; Photodynamic therapy (PDT); Photofrin; Prostate tumor

Indexed keywords

GLUTATHIONE; OXYGEN; PHOTOFRIN; PHOTOSENSITIZING AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DAMAGE; CELL SIZE; CLONOGENESIS; CONTROLLED STUDY; ELECTRON MICROSCOPY; ENDOTHELIUM CELL; FEMALE; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; OXYGEN CONCENTRATION; PHOTODYNAMIC THERAPY; PLOIDY; PRIORITY JOURNAL; PROSTATE TUMOR; RAT; TUMOR CELL;

RATTUS; RODENTIA;

EID: 34547741716     PISSN: 15721000     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pdpdt.2006.12.003     Document Type: Article

References (43)

1. Jocham D., Baumgartner R., Stepp H., and Unsold E. Clinical experience with the integral photodynamic therapy of bladder carcinoma. J Photochem Photobiol B 6 (1990) 183-187
2. Nseyo U.O., Shumaker B., Klein E.A., Sutherland K, and for the bladder Photofrin study group. Photodynamic therapy using porfimer sodium as an alternative to cystectomy in patients with refractory transitional cell carcinoma in situ of the bladder. J Urol 160 (1998) 39-44
3. Allison R.R., Mota H.C., and Sibata C.H. Clinical PD/PDT in North America: an historical review. Photodiagn Photodyn Ther 1 (2004) 263-277
4. Pandey R.K., Bellnier D.A., Smith K.M., and Doughtery T.J. Chlorine and porphyrin derivatives as potential photosensitizers and photodynamic therapy. Photochem Photobiol 53 (1991) 65-72
5. Foote C.S. Mechanisms of photo-oxygenation. In: Dorin D.R., and Gomer C.G. (Eds). Porphyrin localization and treatment of tumors (1984), Alan R. Liss, New York 301-334
6. Henderson B.W., and Miller A.C. Effects of scavengers of reactive oxygen and radical species on cell survival following photodynamic treatment in vitro: comparison to ionizing radiation. Radiat Res 108 (1986) 196-205
7. Hilf R., Murant R.S., Narayanan U., and Gibson S.L. Relationship of mitochondrial function and cellular adenosine triphosphate levels to hematoporphyrin derivatives-induced photosensitization in R-3230-AC mammary tumors. Cancer Res 46 (1986) 211-217
8. Henderson B.W., Waldow S.M., Mang T.S., Potter W.R., Malone P.B., and Dougherty T.J. Tumor destruction and kinetics of tumor cell death in two experimental mouse tumors following photodynamic therapy. Cancer Res 45 (1985) 572
9. Chan W.S., Brasseur N., La Madeleine C., and van Lier J.E. Evidence for different mechanisms of EMT-6 tumor necrosis by photodynamic therapy with disulfonated aluminum phthalocyanine or Photofrin: tumor cell survival and blood flow. Anticancer Res 16 4A (1996) 1887-1892
10. Moore R.B., Chapman J.D., Mercer J.R., et al. Measurement of PDT-induced hypoxia in Dunning prostate tumors by iodine-123-iodoazomycin arabinoside. J Nucl Med 34 (1993) 405-413
11. Gilissen M.J., van de Merbel-de Wit L.E., Star W.M., Koster J.F., and Sluiter W. Effect of photodynamic therapy on the endothelium-dependent relaxation of isolated rat aortas. Cancer Res 53 (1993) 2548-2552
12. Berenbaum M.C., Hall G.W., and Hoyes A.D. Cerebral photosensitization by hematoporphyrin derivative: evidence for endothelial site of action. Br J Cancer 53 (1986) 81-89
13. Chaudhuri K., Keck R.W., and Selman S.H. Morphological changes of tumor microvasculature following hematoporphyrin derivative sensitized photodynamic therapy. Photochem Photobiol 46 (1987) 823-827
14. Gomer C.J., Rucker N., and Murphree A.L. Differential cell photosensitivity following porphyrin photodynamic therapy. Cancer Res 48 (1988) 4539-4542
15. Castano A.P., Demidova T.N., and Hamblin M.R. Mechanism in photodynamic therapy: part one - photosensitizers, photochemistry and cellular localization. Photodiagn Photodyn Ther 1 (2004) 279-293
16. Chapman J.D., McPhee M.S., Walz N., et al. Nuclear magnetic resonance spectroscopy and sensitizer-adduct measurements of photodynamic therapy-induced ischemia in solid tumors. J Natl Cancer Inst 83 (1991) 1650-1659
17. Chapman J.D., Stobbe C.C., Arnfield M.R., Santus R., Lee J., and McPhee M.S. Oxygen dependency of tumor cell killing in vitro by light-activated Photofrin II. Radiat Res 126 (1991) 73-79
18. Thorndyke C., Meeker B.E., Thomas G., Lakey W.H., McPhee M.S., and Chapman J.D. The radiation sensitivities of R3327-H and R3327-AT rat prostatic adenocarcinomas. J Urol 134 (1985) 191-198
19. Vindelov L.L., Christensen I.J., and Nissen N.I. Detergent-trypsin method for the preparation of nuclei for flowcytometric DNA analysis. Cytometry 3 (1983) 323-327
20. Tietze F. Enzymatic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Annual Biochem 27 (1969) 502-522
21. Boegheim J.P., Scholte H., Dubbelman T.M., Beems E., Raap A., and van Steveninck J. Photodynamic effects of hematoporphyrin derivative on enzyme activities of murine L-929 fibroblasts. J Photochem Photobiol B 1 (1987) 61-73
22. 99technetium HMPAO scintigraphy. Br J Cancer 65 (1992) 491-497
23. Xiao Z., Tamimi Y., Brown K., Tulip J., and Moore R. Interstitial photodynamic therapy in subcutaneously implanted urologic tumors in rats after intravenous administration of 5-aminolevulinic acid. Urologic Oncol 7 (2002) 125-132
24. West C.M.L., West D.C., Kumar S., and Moore J.V. A comparison of the sensitivity to photodynamic treatment of endothelial and tumor cells in different proliferative states. Int J Radiat Biol 58 (1990) 145-156
25. Moan J., and Sommer S. Oxygen dependence of photosensitizing effect of hematoporphyrin derivative in NHIK-3025 cells. Cancer Res 45 (1985) 1608-1610
26. Henderson B.W., and Fingar V.H. Relationship of tumor hypoxia and response to photodynamic treatment in an experimental mouse tumor. Cancer Res 47 (1987) 3110-3114
27. Tseng M.T., Reed M.W.R., Ackermann D.M., Schuschke D.A., Wieman T.J., and Miller F.N. Photodynamic therapy induced ultrastructural alterations in microvasculature of the rat cremaster muscle. Photochem Photobiol 48 (1988) 675-681
28. Ali S.M., Olivo M., Yuen G.Y., and Chee S.K. Photodynamic-induced apoptosis of human nasopharyngeal carcinoma cells using Hypocrellins. Intl J Oncol 19 (2001) 633-643
29. Castano A.P., Demidova T.N., and Hamblin M.R. Mechanism in photodynamic therapy: part two-cellular signaling, cell metabolism and modes of cell death. Photodiagn Photodyn Ther 2 (2005) 1-23
30. Heiskanen K.M., Bhat M.B., Wang H.W., Ma J., and Nieminen A. Mitochondrial depolarization accompanies cytochrome c release during apoptosis in PC 6 Cells. J Biol Chem 274 9 (1999) 5654-5658
31. Aoki M., Nata T., Morishita R., et al. Endothelial apoptosis induced by oxidative stress through activation of NF-kB: antiapoptotic effect of antioxidant agents on endothelial cells. Hypertension 38 (2001) 48-55
32. Foster T.H., Primavera M.C., Marder V.J., Hilf R., and Sporn L.A. Photosensitized release of von Willebrand factor from cultured human endothelial Cell. Cancer Res 51 (1991) 3261-3266
33. Fingar V.H., Wieman T.J., and Doak K.W. Mechanistic studies of PDT-induced vascular damage: evidence that eicosanoids mediate this process. Int J Radiat Biol 60 (1991) 303-309
34. Fingar V.H., Wieman T.J., Wiehle S.A., and Cerrito P.B. The role of microvascular damage in photodynamic therapy: the effect of treatment on vessel constriction, permeability and leukocyte adhesion. Cancer Res 52 18 (1992) 4914-4921
35. 2α in acute coronary angioplasty: evidence for oxidant stress during coronary reperfusion in humans. Circulation 96 (1997) 3314-3320
36. Fingar V.H., Wieman T.J., and Doak K.W. Role of Thromboxane and prostacyclin release on photodynamic therapy-induced tumor destruction. Cancer Res 50 (1990) 2599-2603
37. Fingar V.H., Kik P.K., Cerrito P.B., Tseng M., Abang E., and Wieman T.J. Analysis of acute vascular damage after photodynamic therapy using benzoporphyrin derivative (BPD). Br J Cancer 79 (1999) 1702-1708
38. Korbelik M., Krosl G., Olive P.L., and Chaplin D.J. Distribution of Photofrin between tumor cells and tumor associated macrophages. Br J Cancer 64 3 (1991) 508-512
39. Korbelik M., and Krosl G. Cellular levels of photosensitizers in tumors: the role of proximity to the blood supply. Br J Cancer 70 4 (1994) 604-612
40. Korbelik M., Sun J., and Zeng H. Ischemia-reperfusion injury in photodynamic therapy-treated mouse tumors. Br J Cancer 88 5 (2003) 760-766
41. Xiao Z., Brown K., Tulip J., and Moore R.B. Whole bladder photodynamic therapy of orthotopic superficial bladder cancer in rats: a study of intravenous and intravesical administration of photosensitizers. J Urol 169 1 (2003) 352-356
42. Nathan T.R., Whitelaw B.E., Chang S.C., et al. Photodynamic therapy for prostate cancer recurrence after radiotherapy: a phase I study. J Urol 168 (2002) 1427-1432
43. Weersink R.A., Bogaards A., Gertner M., et al. Techniques for delivery and monitoring of TOOKAD (WST09)-mediated photodynamic therapy of the prostate: clinical experience and practicalities. J Photochem Photobiol B 79 3 (2005) 211-222